Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Ursodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 50.00 | |
10 mg | In stock | $ 75.00 | |
25 mg | In stock | $ 128.00 | |
50 mg | In stock | $ 192.00 | |
100 mg | In stock | $ 287.00 | |
200 mg | In stock | $ 431.00 | |
500 mg | In stock | $ 819.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 58.00 |
Description | Ursodeoxycholic acid sodium is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, |
Synonyms | Ursodeoxycholate sodium, UDCA Na, Ursodiol sodium, Sodium Ursodeoxycholate, UDCA sodium, Ursodeoxycholic Acid (sodium salt) |
Molecular Weight | 415.57 |
Formula | C24H40NaO4 |
CAS No. | 2898-95-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 120 mg/mL (289.47 mM), ultrasonic and warming and heat to 60°C
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ursodeoxycholic acid sodium 2898-95-5 GPCR/G Protein Metabolism Endogenous Metabolite GPCR19 FXR gastrointestinal diseases Ursodeoxycholate sodium lipid metabolism Ursodeoxycholate GPBAR1 intestinal barrier integrity NR1H4 Ursodeoxycholic acid G-protein coupled receptor 19 hepatic UCDA inhibit oral Inhibitor G protein-coupled Bile Acid Receptor 1 UDCA Na Ursodiol sodium Sodium Ursodeoxycholate Ursodiol secondary bile acid UDCA sodium Ursodeoxycholic Acid (sodium salt) TGR5 inhibitor